• Currently, the Indian pharma industry is mostly an export-oriented sector. • When the drug patient got expired, we made the generic version, took the approval, and then it is sold off. This is what the Indian pharma company had done in the last 15-20 years and did it very well. • We were always dependent on the US, UK, and other markets. India’s Pharma Sector is quite small as compared with the developed nations with a lot of competition. • The impact of the growth is always at risk due to the regulation of the other countries. • The Pharma Sector of India faces two major risks: International Growth Risk and Regulatory Risk. • Also as of now, there is hardly any R & D in India.